Bio

Mark Secrest is a Managing Director within BTIG Healthcare Investment Banking, focused on medical devices, life sciences tools and diagnostics companies. Prior to BTIG, he was a Managing Director and Head of Medical Devices M&A in Healthcare Investment Banking at Stifel. Previously, Mr. Secrest held several investment banking roles at Cowen between 1998 and 2010, including Head of Medical Technology M&A and Chairman of their Fairness Opinion Review Committee. Between 1995 and 1998, he was a Director in the M&A division at UBS. Mr. Secrest was instrumental in the development and growth of UBS’ M&A effort, and was responsible for the execution of the firm’s M&A assignments for North American clients outside of financial institutions. He began his career in the M&A team at Kidder, Peabody. Mr. Secrest earned a BA from Stanford University, and an MBA from the Stern School of Business at New York University.